Homecare Homebase Earns HIPAA Milestone for De-identification of PHI

DALLAS, Texas—Homecare HomebaseSM (HCHB), a software provider for home-based care, has completed a Re-Identification Risk Determination (RRD). 

The evaluation determined that HCHB’s encounter notes dataset, when de-identified following HCHB’s comprehensive de-identification methodology, is fully compliant with HIPAA’s Expert Determination Standard. Company officials said this milestone supports HCHB’s plans of developing and launching secure artificial intelligence (AI) tools to predict hospitalization risk and support clinical documentation while upholding ethical data use and patient privacy.

“Meeting the HIPAA Expert Determination Standard is crucial in our mission to responsibly and ethically leverage and develop AI-enabled tools,” said Haley Woods, director of product management, AI and innovation at HCHB. “It allows us to confidently use data sets across diverse regions, significantly reducing potential biases and making our AI solutions scalable and beneficial for health care providers.”

The ethical application of AI in health care is critical to addressing risks such as biased recommendations, security breaches and compliance violations. HCHB said by undergoing the RRD, HCHB reinforces its commitment to building ethical, sustainable AI tools while maintaining a focus on data privacy. 

“Our commitment to ethical AI reflects our dedication to delivering technology that supports both exceptional patient care and clinician efficiency,” said Luke Rutledge, president of HCHB. “By meeting rigorous compliance standards, we strengthen clinician trust, allowing them to focus more on patient interaction rather than administrative tasks.”

The determination will enhance HCHB’s initiatives for launching its first suite of AI-powered products designed to enhance predictive analytics and clinical documentation processes this summer, with additional innovations scheduled for subsequent release. For more information about HCHB’s use of ethical AI and its soon-to-be-released AI-powered product suite, go to hchb.com.